Citations (9)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Stephanie Chen, Elyse Swallow, Nanxin Li, Elizabeth Faust, Caroline Kelley, Jipan Xie & Eric Wu. (2015) Economic benefits associated with beta blocker persistence in the treatment of hypertension: a retrospective database analysis. Current Medical Research and Opinion 31:4, pages 615-622.
Read now
Read now
Jasmina Varagic, Henry Punzi & Carlos M Ferrario. (2014) Clinical utility of fixed-dose combinations in hypertension: evidence for the potential of nebivolol/valsartan. Integrated Blood Pressure Control 7, pages 61-70.
Read now
Read now
Stephanie Chen, Stavros Tourkodimitris & Tatjana Lukic. (2014) Economic impact of switching from metoprolol to nebivolol for hypertension treatment: a retrospective database analysis. Journal of Medical Economics 17:10, pages 685-690.
Read now
Read now
Stephanie Chen, Dendy Macaulay, Elyse Swallow, Melissa Diener, Saif Farooqui, Jipan Xie & Eric Q. Wu. (2014) Real-world adherence and persistence associated with nebivolol or hydrochlorothiazide as add-on treatment for hypertension. Current Medical Research and Opinion 30:4, pages 637-643.
Read now
Read now
Articles from other publishers (5)
Arrigo F. G. Cicero, Masanari Kuwabara & Claudio Borghi. (2018) A Critical Review of Nebivolol and its Fixed-Dose Combinations in the Treatment of Hypertension. Drugs 78:17, pages 1783-1790.
Crossref
Crossref
Brent Egan, John Flack, Mehul Patel & Sofia Lombera. (2018) Insights on β-blockers for the treatment of hypertension: A survey of health care practitioners. The Journal of Clinical Hypertension 20:10, pages 1464-1472.
Crossref
Crossref
Rajeev Ayyagari, Jipan Xie, David Cheng, Eric Q. Wu, Xing-Yue Huang & Stephanie Chen. (2018) A retrospective study evaluating the tolerability and effectiveness of adjunctive antihypertensive drugs in patients with inadequate response to initial treatment. The Journal of Clinical Hypertension 20:6, pages 1058-1066.
Crossref
Crossref
Jun Gu, Yu-qi Fan, Ling Bian, Hui-li Zhang, Zuo-jun Xu, Yang Zhang, Qi-zhi Chen, Zhao-fang Yin, Yu-shui Xie & Chang-qian Wang. (2016) Long-term prescription of beta-blocker delays the progression of heart failure with preserved ejection fraction in patients with hypertension: A retrospective observational cohort study. European Journal of Preventive Cardiology 23:13, pages 1421-1428.
Crossref
Crossref
Yun Jung Choi, Young‐Mi Ah, Jisun Kong, Kyung Hee Choi, Baegeum Kim, Nayoung Han, Yun Mi Yu, Jung Mi Oh, Wan Gyoon Shin, Hae‐Young Lee & Ju‐Yeun Lee. (2016) Implication of different initial beta blockers on treatment persistence: atenolol vs new‐generation beta blocker, a population‐based study. Cardiovascular Therapeutics 34:4, pages 268-275.
Crossref
Crossref